Baird Maintains Neutral on Inspire Medical Systems, Raises Price Target to $77
Benzinga Newsdesk 5 hours ago
Analyst RatingsNewsPrice Target
Baird analyst Mike Polark maintains Inspire Medical Systems (NYSE:INSP) with a Neutral and raises the price target from $73 to $77.
Baird analyst Mike Polark maintains Inspire Medical Systems (NYSE:INSP) with a Neutral and raises the price target from $73 to $77.